🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 12 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/02/2010 18,24 19,02 17,94 18,90 +2,27% 5,92% 29.617
24/02/2010 18,66 18,78 18,36 18,48 -0,65% 2,25% 15.250
23/02/2010 18,72 18,84 18,30 18,60 -0,64% 2,88% 24.933
22/02/2010 18,66 19,08 18,12 18,72 +0,32% 5,14% 55.083
19/02/2010 18,90 18,90 18,18 18,66 -1,27% 3,81% 20.067
18/02/2010 18,84 18,90 18,18 18,90 +0,00% 3,82% 18.267
17/02/2010 18,90 18,90 18,30 18,90 +0,64% 3,17% 29.467
16/02/2010 18,60 18,84 18,42 18,78 +1,62% 2,26% 23.900
12/02/2010 18,06 18,48 17,70 18,48 +1,65% 4,32% 37.083
11/02/2010 17,76 18,24 17,46 18,18 +2,36% 4,39% 27.367
10/02/2010 18,00 18,48 17,22 17,76 -1,99% 7,00% 42.733
09/02/2010 18,60 18,72 17,94 18,12 -1,31% 4,19% 21.050
08/02/2010 18,12 18,48 18,00 18,36 +1,66% 2,65% 38.383
05/02/2010 18,66 18,66 17,52 18,06 -3,22% 6,11% 67.433
04/02/2010 18,72 19,38 18,30 18,66 +4,01% 5,77% 82.350
03/02/2010 18,60 18,90 17,94 17,94 -3,86% 5,16% 37.883
02/02/2010 18,42 18,84 18,06 18,66 +2,30% 4,23% 32.050
01/02/2010 18,24 18,30 17,70 18,24 +0,66% 3,29% 50.617
29/01/2010 17,58 18,54 17,46 18,12 +3,42% 6,14% 43.183
28/01/2010 18,00 18,18 17,46 17,52 -2,01% 4,00% 34.867
27/01/2010 18,24 18,30 17,70 17,88 +0,68% 3,29% 31.667
26/01/2010 18,18 18,60 17,70 17,76 -2,31% 4,95% 31.567
25/01/2010 18,24 18,48 17,82 18,18 +0,66% 3,62% 64.283
22/01/2010 18,30 18,30 17,82 18,06 -1,63% 2,62% 101.067
21/01/2010 18,12 18,78 17,58 18,36 +1,66% 6,62% 79.967
20/01/2010 19,38 19,56 18,06 18,06 -7,95% 7,74% 99.967
19/01/2010 20,04 20,46 19,26 19,62 -1,51% 5,99% 47.733
15/01/2010 21,36 21,54 19,56 19,92 -6,21% 9,27% 58.550
14/01/2010 20,34 21,60 20,16 21,24 +4,42% 7,08% 41.583
13/01/2010 19,62 20,52 19,26 20,34 +3,99% 6,42% 34.800